A recent study also found that susceptibility to inflammasome activation was correlated with a higher likelihood of cognitive deficits in AD patients.218 Additionally, AIM2 and NLRP1 inflammasomes in particular have been implicated in AD as Alzheimer’s patients have increased NLRP1 expression in their brains. This evidence concerns the gene NLRP1 and Alzheimer disease.